Hamilton Thorne (TSE:HTL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hamilton Thorne Ltd has secured shareholder approval for its ‘going private’ transaction, with over 99.98% support from voting shareholders, excluding certain minority votes. The company, a leader in Assisted Reproductive Technologies (ART), also announced imminent finalization of its acquisition of Cook Medical’s ART portfolio and expected regulatory clearances, anticipating the deal’s closure in Q4 2024. Post-transaction, Hamilton Thorne will be delisted from the TSX and will stop being a reporting issuer in Canada.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.